References
- AshmanLKThe biology of stem cell factor and its receptor c-kitInt J Biochem Cell Biol199931101037105110582338
- FuritsuTTsujimuraTTonoTIdentification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit productJ Clin Invest199392417367691885
- YavuzASLipskyPEYavuzSMetcalfeDDAkinCEvidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit geneBlood2002100266166512091362
- CorlessCLFletcherJAHeinrichMCBiology of gastrointestinal stromal tumorsJ Clin Oncol200422183813382515365079
- YardenYKuangWJYang-FengTHuman proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligandEMBO J198761133412448137
- GiebelLStrunkKHolmesSSpritzROrganization and nucleotide sequence of the human KIT (mast/stem cell growth factor receptor) proto-oncogeneOncogene1992711220722171279499
- UllrichASchlessingerJSignal transduction by receptors with tyrosine kinase activityCell19906122032122158859
- ReithAEllisCLymanSSignal transduction by normal isoforms and W mutant variants of the Kit receptor tyrosine kinaseEMBO J199110924511714377
- VoytyukOLennartssonJMogiASrc family kinases are involved in the differential signaling from two splice forms of c-KitJ Biol Chem2003278119159916612511554
- MaulikGBhartiAKhanEBroderickRJKijimaTSalgiaRModulation of c-Kit/SCF pathway leads to alterations in topoisomerase-I activity in small cell lung cancerJ Environ Pathol Toxicol Oncol200423423725115511212
- PawsonTProtein modules and signalling networksNature199537365155735807531822
- Blume-JensenPSiegbahnAStabelSHeldinCHRönnstrandLIncreased Kit/SCF receptor induced mitogenicity but abolished cell motility after inhibition of protein kinase CEMBO J1993121141997693453
- ZhuWMDongWFMindenMAlternate splicing creates two forms of the human kit proteinLeuk Lymphoma1994125–64414477514064
- CrosierPRicciardiSTHallLRVitasMRClarkSCCrosierKEExpression of isoforms of the human receptor tyrosine kinase c-kit in leukemic cell lines and acute myeloid leukemiaBlood1993824115111587688988
- CaruanaGCambareriACAshmanLKIsoforms of c-KIT differ in activation of signalling pathways and transformation of NIH3T3 fibroblastsOncogene1999185573558110523834
- HuangENockaKBuckJBesmerPDifferential expression and processing of two cell associated forms of the kit-ligand: KL-1 and KL-2Mol Biol Cell1992333493621378327
- AlbanesiCGeremiaRGiorgioMDolciSSetteCRossiPA cell- and developmental stage-specific promoter drives the expression of a truncated c-kit protein during mouse spermatid elongationDevelopment19961224129113028620856
- ParonettoMPFariniDSammarcoIExpression of a truncated form of the c-Kit tyrosine kinase receptor and activation of Src kinase in human prostatic cancerAm J Pathol200416441243125115039213
- SakamotoAYonedaATeradaKA functional truncated form of c-kit tyrosine kinase is produced specifically in the testis of the mouse but not the rat, pig, or humanBiochem Genet20044211–1244145115587987
- DaSilvaNHuZMaWRosnetOBirnbaumDDrexlerHExpression of the FLT3 gene in human leukemia-lymphoma cell linesLeukemia1994858858888182945
- HuZBMaWUphoffCQuentmeierHDrexlerHc-kit expression in human megakaryoblastic leukemia cell linesBlood1994838213321447512841
- RussellESHereditary anemias of the mouse: a review for geneticistsAdv Genet197920357390999
- KeshetELymanSWilliamsDEmbryonic RNA expression patterns of the c-kit receptor and its cognate ligand suggest multiple functional roles in mouse developmentEMBO J199110924251714375
- LevSBlechmanJMGivolDYardenYSteel factor and c-kit protooncogene: genetic lessons in signal transductionCrit Rev Oncog199452–31411687531500
- OkadaSNakauchiHNagayoshiKNishikawaSMiuraYSudaTEnrichment and characterization of murine hematopoietic stem cells that express c-kit moleculeBlood1991787170617121717068
- BroudyVCStem cell factor and hematopoiesisBlood1997904134513649269751
- LymanSDJacobsenSEWc-Kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activitiesBlood1998914110111349454740
- AshmanLKCambareriACToLBLevinskyRJJuttnerCAExpression of the YB5. B8 antigen (c-kit proto-oncogene product) in normal human bone marrowBlood199178130371712644
- PapayannopoulouTBriceMBroudyVCZseboKMIsolation of c-kit receptor-expressing cells from bone marrow, peripheral blood, and fetal liver: functional properties and composite antigenic profileBlood1991786140314121715789
- BroudyVCSmithFLinNZseboKEgrieJBernsteinIBlasts from patients with acute myelogenous leukemia express functional receptors for stem cell factorBlood199280160671377054
- OliveiraSLukacsNStem cell factor: a hemopoietic cytokine with important targets in asthmaCurr Drug Targets Inflamm Allergy20032431331814561150
- WaskowCPaulSHallerCGassmannMRodewaldHRViable c-Kit W/W mutants reveal pivotal role for c-kit in the maintenance of lymphopoiesisImmunity200217327728812354381
- LovelandKSchlattSStem cell factor and c-kit in the mammalian testis: lessons originating from Mother Nature’s gene knockoutsJ Endocrinol199715333373449203987
- Blume-JensenPJanknechtRHunterTThe kit receptor promotes cell survival via activation of PI 3-kinase and subsequent Akt-mediated phosphorylation of Bad on Ser136Curr Biol19988137797859651683
- KisselHTimokhinaIHardyMPPoint mutation in kit receptor tyrosine kinase reveals essential roles for kit signaling in spermatogenesis and oogenesis without affecting other kit responsesEMBO J20001961312132610716931
- ScottGEwingJRyanDAbboudCStem cell factor regulates human melanocyte-matrix interactionsPigment Cell Res19947144517521051
- MackenzieMAJordanSABuddPSJacksonIJActivation of the receptor tyrosine kinase Kit is required for the proliferation of melanoblasts in the mouse embryoDev Biol19971921991079405100
- Wehrle-HallerBThe role of Kit-ligand in melanocyte development and epidermal homeostasisPigment Cell Res200316328729612753403
- KimuraYJonesNKlüppelMTargeted mutations of the juxtamembrane tyrosines in the Kit receptor tyrosine kinase selectively affect multiple cell lineagesProc Natl Acad Sci U S A2004101166015602015067126
- LyfordGHeCSofferEPan-colonic decrease in interstitial cells of Cajal in patients with slow transit constipationGut200251449650112235070
- HuizingaJDThunebergLKluppelMMalyszJMikkelsenHBBernsteinAW/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activityNature199537365123473497530333
- WardSMBurnsAJTorihashiSHarneySCSandersKMImpaired development of interstitial cells and intestinal electrical rhythmicity in steel mutantsAm J Physiol19952696C1577C15858572188
- WardSMBurnsAJTorihashiSSandersKMMutation of the proto-oncogene c-kit blocks development of interstitial cells and electrical rhythmicity in murine intestineJ Physiol1994480191977853230
- JinKMaoXOSunYXieLGreenbergDAStem cell factor stimulates neurogenesis in vitro and in vivoJ Clin Invest2002110331131912163450
- SunLLeeJFineHANeuronally expressed stem cell factor induces neural stem cell migration to areas of brain injuryJ Clin Invest20041139136415124028
- AshmanLKGriffithRTherapeutic targeting of c-KIT in cancerExpert Opin Investig Drugs2013221103115
- LennartssonJJelacicTLinnekinDShivakrupaRNormal and oncogenic forms of the receptor tyrosine kinase kitStem Cells2005231164315625120
- HuangSLucaMGutmanMEnforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potentialOncogene19961311233923478957075
- Willmore-PayneCHoldenJATrippSLayfieldLJHuman malignant melanoma: detection of BRAF-and c-kit–activating mutations by high-resolution amplicon melting analysisHum Pathol200536548649315948115
- D’AmatoGSteinertDMMcAuliffeJCTrentJCUpdate on the biology and therapy of gastrointestinal stromal tumorsCancer Control2005121445615668652
- HirotaSIsozakiKMoriyamaYGain-of-function mutations of c-kit in human gastrointestinal stromal tumorsScience199827953505775809438854
- KellyLMGillilandDGGenetics of myeloid leukemiasAnnu Rev Genomics Hum Genet20023117919812194988
- Hoei-HansenCEKraggerudSMAbelerVMKærnJRajpert-De MeytsELotheRAOvarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markersMol Cancer2007611217274819
- BeadlingCJacobson-DunlopEHodiFSKIT gene mutations and copy number in melanoma subtypesClin Cancer Res200814216821682818980976
- HeinrichMCBlankeCDDrukerBJCorlessCLInhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignanciesJ Clin Oncol20022061692170311896121
- CatalanoARodilossiSRippoMRCaprariPProcopioAInduction of stem cell factor/c-Kit/slug signal transduction in multidrug-resistant malignant mesothelioma cellsJ Biol Chem200427945467064671415337769
- IkedaHKanakuraYTamakiTExpression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemia cellsBlood19917811296229681720040
- HuoLSugimuraJTretiakovaMSc-kit expression in renal oncocytomas and chromophobe renal cell carcinomasHum Pathol200536326226815791570
- RodriguesGAParkMOncogenic activation of tyrosine kinasesCurr Opin Genet Devel19944115248193535
- KitayamaHKanakuraYFuritsuTConstitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell linesBlood19958537907987530509
- MoriyamaYTsujimuraTHashimotoKRole of aspartic acid 814 in the function and expression of c-kit receptor tyrosine kinaseJ Biol Chem19962717334733508631931
- LamLChowRBergerSA transforming mutation enhances the activity of the c-Kit soluble tyrosine kinase domainBiochem J19993381311389931308
- TsujimuraTHashimotoKKitayamaHActivating mutation in the catalytic domain of c-kit elicits hematopoietic transformation by receptor self-association not at the ligand-induced dimerization siteBlood1999934131913299949175
- CasteranNDe SepulvedaPBesluNSignal transduction by several KIT juxtamembrane domain mutationsOncogene200322304710472212879016
- PiaoXPaulsonRVan Der GeerPPawsonTBernsteinAOncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1Proc Natl Acad Sci U S A1996932514665146698962111
- NaoeTKiyoiHNormal and oncogenic FLT3Cell Mol Life Sci200461232932293815583855
- HongyoTLiTSyaifudinMSpecific c-kit mutations in sinonasal natural killer/T-cell lymphoma in China and JapanCancer Res20006092345234710811105
- BüttnerCHenzBMWelkerPSeppNTGrabbeJIdentification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behaviorJ Investig Dermatol19981116122712319856847
- AshmanLKFerraoPColeSRCambareriACEffects of mutant c-kit in early myeloid cellsLeuk Lymphoma1999345–645146110492068
- BeghiniAPeterlongoPRipamontiCBc-kit mutations in core binding factor leukemiasBlood200095272672810660321
- TianQFriersonHFKrystalGWMoskalukCAActivating c-kit gene mutations in human germ cell tumorsAm J Pathol199915461643164710362788
- PaulsKWardelmannEMerkelbach-BruseSBüttnerRZhouHc-KIT codon 816 mutation in a recurrent and metastatic dysgerminoma of a 14-year-old girl: case studyVirchows Arch2004445665165415455230
- SakumaYSakuraiSOguniSSatohMHironakaMSaitoKc-Kit gene mutations in intracranial germinomasCancer Sci200495971672015471556
- NagataHWorobecASOhCKIdentification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorderProc Natl Acad Sci U S A1995922310560105647479840
- LongleyBJTyrrellLLuSZSomatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasmNature Genet19961233123148589724
- LinZHHanEMLeeESA distinct expression pattern and point mutation of c-kit in papillary renal cell carcinomasMod Pathol200417661161615073597
- HubbardSRJuxtamembrane autoinhibition in receptor tyrosine kinasesNat Rev Mol Cell Biol20045646447115173825
- DiNittoJPDeshmukhGDZhangYFunction of activation loop tyrosine phosphorylation in the mechanism of c-Kit auto-activation and its implication in sunitinib resistanceJ Biochem2010147460160920147452
- MorganSJSmithADParkerPJPurification and characterization of bovine brain type I phosphatidylinositol kinaseEur J Biochem199019137617672167854
- EngströmMKarlssonRJönssonJIInactivation of the forkhead transcription factor FoxO3 is essential for PKB-mediated survival of hematopoietic progenitor cells by kit ligandExp Hematol200331431632312691919
- MöllerCAlfredssonJEngströmMStem cell factor promotes mast cell survival via inactivation of FOXO3a-mediated transcriptional induction and MEK-regulated phosphorylation of the proapoptotic protein BimBlood200510641330133615855272
- MöllerCAlfredssonJEngströmMStem cell factor promotes mast cell survival via inactivation of FOXO3a-mediated transcriptional induction and MEK-regulated phosphorylation of the proapoptotic protein BimBlood200510641330133615855272
- VossellerKStellaGYeeNBesmerPc-Kit receptor signaling through its phosphatidylinositide-3′-kinase-binding site and protein kinase C: role in mast cell enhancement of degranulation, adhesion, and membrane rufflingMol Biol Cell1997859099229168474
- HashimotoKMatsumuraITsujimuraTNecessity of tyrosine 719 and phosphatidylinositol 3′-kinase–mediated signal pathway in constitutive activation and oncogenic potential of c-kit receptor tyrosine kinase with the Asp814Val mutationBlood200310131094110212393643
- ShivakrupaRBernsteinAWatringNLinnekinDPhosphatidylinositol 3′-kinase is required for growth of mast cells expressing the kit catalytic domain mutantCancer Res200363154412441912907613
- ArcaroAKhanzadaUKVanhaesebroeckBTetleyTDWaterfieldMDSecklMJTwo distinct phosphoinositide 3-kinases mediate polypeptide growth factor-stimulated PKB activationEMBO J200221195097510812356726
- BenesCHWuNEliaAEDhariaTCantleyLCSoltoffSPThe C2 domain of PKCδ is a phosphotyrosine binding domainCell2005121227128015851033
- BromannPAKorkayaHCourtneidgeSAThe interplay between Src family kinases and receptor tyrosine kinasesOncogene200423487957796815489913
- LinnekinDDeBerryCSMouSLyn associates with the juxtamembrane region of c-Kit and is activated by stem cell factor in hematopoietic cell lines and normal progenitor cellsJ Biol Chem19972724327450274559341198
- KrystalGWDeBerryCSLinnekinDLitzJLck associates with and is activated by Kit in a small cell lung cancer cell line: inhibition of SCF-mediated growth by the Src family kinase inhibitor PP1Cancer Res19985820466046669788619
- BroudyVCLinNLLilesWCSignaling via Src family kinases is required for normal internalization of the receptor c-KitBlood19999461979198610477727
- ShivakrupaRLinnekinDLyn contributes to regulation of multiple Kit-dependent signaling pathways in murine bone marrow mast cellsCell Signal200517110310915451030
- HongLMunugalavadlaVKapurRc-Kit-mediated overlapping and unique functional and biochemical outcomes via diverse signaling pathwaysMol Cell Biol20042431401141014729982
- WollbergPLennartssonJGottfridssonEYoshimuraARonnstrandLThe adapter protein APS associates with the multifunctional docking sites Tyr-568 and Tyr-936 in c-KitBiochem J20033701033103812444928
- KozlowskiMLaroseLLeeFLeDMRottapelRSiminovitchKASHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domainMol Cell Biol1998184208920999528781
- AgostiVCorbaciogluSEhlersICritical role for Kit-mediated Src kinase but not PI 3-kinase signaling in pro T and pro B cell developmentJ Exp Med2004199686787815024050
- MurphyLOSmithSChenRHFingarDCBlenisJMolecular interpretation of ERK signal duration by immediate early gene productsNat Cell Biol20024855656412134156
- ThommesKLennartssonJCarlbergMRonnstrandLIdentification of Tyr-703 and Tyr-936 as the primary association sites for Grb2 and Grb7 in the c-Kit/stem cell factor receptorBiochem J199934121121610377264
- HosseinimehrSJInanamiOHamasuTActivation of c-kit by stem cell factor induces radioresistance to apoptosis through ERK-dependent expression of survivin in HL60 cellsJ Radiat Res200445455756115635266
- LennartssonJWernstedtCEngströmUHellmanURönnstrandLIdentification of Tyr900 in the kinase domain of c-Kit as a Src-dependent phosphorylation site mediating interaction with c-CrkExp Cell Res2003288111011812878163
- BrizziMFZiniMGAronicaMGBlechmanJMYardenYPegoraroLConvergence of signaling by interleukin-3, granulocyte-macrophage colony-stimulating factor, and mast cell growth factor on JAK2 tyrosine kinaseJ Biol Chem19942695031680316847527392
- Pérez-LosadaJSánchez-MartıńMRodríguez-GarcıáAZinc-finger transcription factor Slug contributes to the function of the stem cell factor c-kit signaling pathwayBlood200210041274128612149208
- LennartssonJRonnstrandLThe stem cell factor receptor/c-Kit as a drug target in cancerCurr Cancer Drug Targets200661657516475976
- DeiningerMBuchdungerEDrukerBJThe development of imatinib as a therapeutic agent for chronic myeloid leukemiaBlood200510572640265315618470
- WakitaSYamaguchiHMiyakeKImportance of c-kit mutation detection method sensitivity in prognostic analyses of t (8; 21)(q22; q22) acute myeloid leukemiaLeukemia20112591423143221606963
- Willmore-PayneCLayfieldLJHoldenJAc-Kit mutation analysis for diagnosis of gastrointestinal stromal tumors in fine needle aspiration specimensCancer Cytopathol20051053165170
- FrostMJFerraoPTHughesTPAshmanLKJuxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-Kit whereas the kinase domain mutant D816VKit is resistantMol Cancer Ther20021121115112412481435
- RobertsKGOdellAFByrnesEMResistance to c-KIT kinase inhibitors conferred by V654A mutationMol Cancer Ther2007631159116617363509
- KrügerSSotlarKKauschIHornyHPExpression of KIT (CD117) in renal cell carcinoma and renal oncocytomaOncology2005682–326927516015044
- CorbinASDemehriSGriswoldIJIn vitro and in vivo activity of ATP-based kinase inhibitors AP23464 and AP23848 against activation-loop mutants of KitBlood2005106122723415746079
- WangYYZhouGBYinTAML1-ETO and c-KIT mutation/overexpression in t (8; 21) leukemia: implication in stepwise leukemogenesis and response to GleevecProc Natl Acad Sci U S A200510241104110915650049
- ChanIKasprowiczSTharpMDistinct signalling pathways for mutated KIT (V560G) and KIT (D816V) in mastocytosisClin Exp Dermatol201338553854423777495
- LanternierFCohen-AkenineAPalmeriniFPhenotypic and genotypic characteristics of mastocytosis according to the age of onsetPLoS One200834e190618404201
- SchnittgerSKohlTMHaferlachTKIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survivalBlood200610751791179916254134
- SakumaYSakuraiSOguniSHironakaMSaltoKAlterations of the c-kit gene in testicular germ cell tumorsCancer Sci200394648649112824871
- OrfaoAGarcia-MonteroACSanchezLEscribanoLRecent advances in the understanding of mastocytosis: the role of KIT mutationsBr J Haematol20071381123017555444
- NakataYKimuraAKatohOc-Kit point mutation of extracellular domain in patients with myeloproliferative disordersBr J Haematol19959136616638555071
- KimuraANakataYKatohOHyodoHc-Kit point mutation in patients with myeloproliferative disordersLeuk Lymphoma1997253–42812879168438
- ScheijenBGriffinJDTyrosine kinase oncogenes in normal hematopoiesis and hematological diseaseOncogene200221213314333312032772
- MakiRKeedyV2012KIT Exon 14 Mutation in GIST [webpage on the Internet]My Cancer Genome Available from: https://www.mycancergenome.org/content/disease/gist/kit/50/Accessed April 21, 2016
- HeinrichMCGriffithDJDrukerBJWaitCLOttKAZiglerAJInhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitorBlood200096392593210910906
- TuvesonDAWillisNAJacksTSTI 571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implicationsOncogene200120365054505811526490
- AttoubSRivatCRodriguesSThe c-kit tyrosine kinase inhibitor STI571 for colorectal cancer therapyCancer Res200262174879488312208734
- WeisbergEBoultonCKellyLMInhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412Cancer Cell20021543344312124173
- WheelerSSeegmillerAVnencak-JonesA2013KIT c.2447A>T (D816V) Mutation in Acute Myeloid Leukemia [webpage on the Internet]My Cancer Genome Available from: https://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/275/Accessed April 21, 2016
- YeeKWO’FarrellAMSmolichBDSU5416 and SU5614 inhibit kinase activity of wild-type and mutant FLT3 receptor tyrosine kinaseBlood200210082941294912351406
- SmolichBDYuenHAWestKAGilesFJAlbitarMCherringtonJMThe antiangiogenic protein kinase inhibitors SU5416 and SU6668 inhibit the SCF receptor (c-kit) in a human myeloid leukemia cell line and in acute myeloid leukemia blastsBlood20019751413142111222388
- KimDWJoYSJungHSAn orally administered multitarget tyrosine kinase inhibitor, SU11248, is a novel potent inhibitor of thyroid oncogenic RET/papillary thyroid cancer kinasesJ Clin Endocrinol Metabol2006911040704076
- Von BubnoffNGorantlaSKanchaRLordickFPeschelCDuysterJSpotlight correspondenceLeukemia2005191670167116015383
- LovlyCPaoWSosmanJ2015KIT c.2446G>C (D816H) Mutation in Melanoma [webpage on the Internet]My Cancer Genome Available from: https://www.mycancergenome.org/content/disease/melanoma/kit/84/Accessed April 21, 2016
- SambolEBAmbrosiniGGehaRCFlavopiridol targets c-KIT transcription and induces apoptosis in gastrointestinal stromal tumor cellsCancer Res200666115858586616740725
- BelloneGSilvestriSArtusioEGrowth stimulation of colorectal carcinoma cells via the c-kit receptor is inhibited by TGF-β1J Cell Physiol199717211119207920
- CurtinJABusamKPinkelDBastianBCSomatic activation of KIT in distinct subtypes of melanomaJ Clin Oncol200624264340434616908931
- TerheydenPHoubenRPajouhPThornsCZillikensDBeckerJCResponse to imatinib mesylate depends on the presence of the V559A-mutated KIT oncogeneJ Investig Dermatol2010130131431619812602
- WoodmanSETrentJCStemke-HaleKActivity of dasatinib against L576P KIT mutant melanoma: molecular, cellular, and clinical correlatesMol Cancer Ther2009882079208519671763
- Quintás-CardamaALazarAJWoodmanSEKimKRossMHwuPComplete response of stage IV anal mucosal melanoma expressing KIT Val560Asp to the multikinase inhibitor sorafenibNat Clin Pract Oncol200851273774018936790
- CarvajalRDAntonescuCRWolchokJDKIT as a therapeutic target in metastatic melanomaJAMA2011305222327233421642685
- HaradaHHaradaYNiimiHKyoTKimuraAInabaTHigh incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasiaBlood200410362316232414615365
- GuoJSiLKongYPhase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplificationJ Clin Oncol201129212904290921690468
- GirardN2015KIT c.2460T>A (D820E) Mutation in Thymic Carcinoma [webpage on the Internet]My Cancer Genome Available from: https://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/120/Accessed April 21, 2016
- ButiSDoniniMSergioPImpressive response with imatinib in a heavily pretreated patient with metastatic c-KIT mutated thymic carcinomaJ Clin Oncol20112933e803e80521969494
- SchirosiLNanniniNNicoliDActivating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitorsAnn Oncol20122392409241422357254
- AntonescuCRSommerGSarranLAssociation of KIT exon 9 mutations with nongastric primary site and aggressive behavior KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumorsClin Cancer Res2003993329333712960119
- RossiFYozgatYde StanchinaEImatinib upregulates compensatory integrin signaling in a mouse model of gastrointestinal stromal tumor and is more effective when combined with dasatinibMol Cancer Res2010891271128320736294
- StröbelPHartmannMJakobAThymic carcinoma with overexpression of mutated KIT and the response to imatinibN Engl J Med2004350252625262615201427
- AntonescuCRBesmerPGuoTAcquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutationClin Cancer Res200511114182419015930355
- YohKNishiwakiYIshiiGMutational status of EGFR and KIT in thymoma and thymic carcinomaLung Cancer200862331632018448188
- DişelUÖztuzcuSBeşenAAPromising efficacy of sorafenib in a relapsed thymic carcinoma with c-KIT exon 11 deletion mutationLung Cancer201171110911220970876
- GuoTAgaramNPWongGCSorafenib inhibits the imatinib-resistant KITT670I gatekeeper mutation in gastrointestinal stromal tumorClin Cancer Res200713164874488117699867
- TimokhinaIKisselHStellaGBesmerPKit signaling through PI 3-kinase and Src kinase pathways: an essential role for Rac1 and JNK activation in mast cell proliferationEMBO J19981721625062629799234
- GoddardNMcIntyreASummersgillBGilbertDKitazawaSShipleyJKIT and RAS signalling pathways in testicular germ cell tumours: new data and a review of the literatureInt J Androl200730433734917573850
- WandziochEEdlingCEPalmerRHCarlssonLHallbergBActivation of the MAP kinase pathway by c-Kit is PI-3 kinase dependent in hematopoietic progenitor/stem cell linesBlood20041041515714996702